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E-mail address: sirizvi@gmail.com (S.I. Rizvi).Diabetes mellitus (TDM) is strongly associated with oxidative stress. Human erythrocytes contain a
plasma membrane redox system (PMRS) which transfers electrons from intracellular donors (NADH,
ascorbate) to extracellular acceptors outside the cell. We show that the activity of erythrocyte PMRS
and AFR reductase becomes elevated in ﬁrst degree relatives of type 2 diabetics and in TDM subjects.
The increase in PMRS and AFR reductase signiﬁes compensatory mechanisms to mitigate increased oxi-
dative stress. These ﬁndings show that an impaired redox balance may be a cause the disturbance of
homeostasis in type 2 diabetic families, even before the development of the disease.
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Epidemiological studies on twins and families have provided a
strong correlation for genetic factors contributing to the etiology
of type 2 diabetes [1]. Diabetes mellitus is strongly associated with
oxidative stress, which can be a consequence of either increased
production of free radicals, reduced antioxidant defense or both
[2]. Despite a large number of studies, it is not clear whether oxi-
dative stress is a factor contributing to the development of diabetic
condition or whether it is a consequence of the disease.
In diabetes mellitus, chronic hyperglycemia produces multiple
biochemical sequels, and diabetes-induced oxidative stress may
play a role in the onset and progression of the disease. Many com-
plications of diabetes, including retinopathy and atherosclerotic
vascular disease, the leading cause of mortality in diabetes, have
been linked to oxidative stress. A rational extension of the pro-
posed role for oxidative stress is the suggestion that the differing
susceptibility of diabetic patients to microvascular and macrovas-
cular complications may be a function of endogenous antioxidant
status [2].
Studies show that human erythrocytes contain a plasma
membrane redox system (PMRS) which transfers electrons from
intracellular donors (NADH and/or ascorbate) to extracellular
acceptors outside the cell, although the physiological acceptor is
still unclear [3]. There is evidence that the intracellular ascorbate
(ASC) donates electrons to extracellular ascorbate free radical
(AFR) via the PMRS which incorporates an AFR reductase; such a
redox system enables the cells to effectively counteract oxidativeellitus. Published by Elsevier Ltd. Oprocesses, thereby preventing the depletion of extracellular ASC
[4].
Recent reports prove that the activity of erythrocyte PMRS and
AFR reductase increase during human aging, an effect which is neg-
atively correlated with decreased plasma antioxidant potential
[5,6]. In view of the increased oxidative stress in diabetic patients,
a condition which is similar to that observed during aging, we have
determined erythrocyte PMRS and AFR reductase in ﬁrst degree
relatives of type 2 diabetic patients (Rel-T2D) and type 2 diabetic
patients in order evaluate the role of oxidative stress in the devel-
opment of frank diabetic state.2. Materials and methods
2.1. Selection of subjects
The study was conducted in normotensive subjects (n = 22) of
age ranging between 30 and 45 with P1 parent diagnosed with
type 2 diabetes (average age 39 years). The activity was compared
with age and sex matched controls (n = 25), (average age 38 years)
having negative family history of type 2 diabetes. Type 2 diabetic
patients of average age 40 years (n = 21) were also included in
the study. The criteria for selecting Rel-T2D and type 2 diabetic pa-
tients was the same as described earlier [7,8]. The fasting blood
glucose level of control subjects was between 76 and 90 mg/dL,
Rel-T2D 79–94 mg/dL and T2D 142–198 mg/dL. To exclude predia-
betic subjects, only those Rel-T2D subjects were selected who had
normal oral glucose tolerance test (OGTT) with a 2 h post load of
glucose <140 mg/dL [9]. None of the subjects had high blood
pressure or microalbuminuria. Care was also taken to exclude
subjects who had a family history of hypertension. All memberspen access under CC BY-NC-ND license.
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The protocol for the study was in accordance with guidelines of the
institutional ethical committee.Fig. 1. Erythrocyte PMRS activity in normal (control), ﬁrst degree relative of type 2
diabetic patients (Rel-T2D), and type 2 diabetic (T2D) patients. aPMRS activity
expressed in terms of lmol ferrocyanide/ml PRBC/30 min. *P < 0.05 compared to
normal.2.2. Collection of blood, isolation of packed RBC and preparation of
ghosts
Venous blood was collected from control and type 2 diabetic pa-
tients after an overnight fast, using ACD as anticoagulant. The
blood samples were centrifuged at 4 C for 10 min at 1000g to re-
move plasma and buffy coat, and the isolated erythrocytes were
washed 4–5 times with 0.154 M NaCl and ﬁnally packed erythro-
cyte (PRBC) was obtained.
Erythrocyte trans-plasma membrane redox activity was esti-
mated by following the reduction of ferricyanide, according to
the method of Avron and Shavit [10]. A 0.2 ml RBC were suspended
in PBS containing 5 mM glucose and 1 mM freshly prepared potas-
sium ferricyanide. The suspensions were incubated for 30 min at
37 C and then centrifuged at 1800g at 4 C. The supernatant col-
lected was assayed for ferrocyanide content using 4,7-diphenyl-
1,10-phenanthrolinedisulfonic acid disodium salt and measuring
absorption at 535 nm (e = 20,500 M1 cm1). Results are expressed
in lmol ferrocyanide/ml PRBC/30 min.
The erythrocyte AFR reductase activity was assayed following
the method as described by May et al. [11]. The washed erythro-
cytes were hemolysed and diluted 100% (v/v) by addition of water
followed by centrifuging for 10 min in the cold. AFR was generated
in diluted hemolysates by incubating them at 37 C in PBS (pH 7.0),
containing 1 mM ascorbate, 5 units/ml ascorbate oxidase, and
0.1 mM of NADH. The rate of NADH oxidation was measured spec-
trophotometrically at 340 nm for 3 min at 37 C. The change in
NADH concentration was calculated from the slope of the resulting
line, using an extinction coefﬁcient e = 6.22 mM1 cm1. The val-
ues were corrected in each experiment for the rate observed with
lysate and reduced nucleotide alone. AFR reductase activity is re-
ported in terms of lmol NADH oxidised/min/ml PRBC.2.3. Statistical analysis
Statistical analyses were performed using GraphPad Prism ver-
sion 4.00 for Windows, GraphPad Software, San Diego, California,
USA. The results were reported as means ± SD from individual
magnitudes. Statistical differences were analyzed with Student’s
t-test, and the differences were considered to be signiﬁcant when
P < 0.05.Fig. 2. Erythrocyte AFR reductase activity in normal (control), ﬁrst degree relatives
of type 2 diabetic patients (Rel-T2D), and type 2 diabetic (T2D) patients. aAFR
reductase activity expressed in terms of lmol NADH oxidised/min/ml PRBC.
*P < 0.05 compared to normal.3. Results and discussion
There is much evidence that oxidative stress is involved in the
etiology of several diabetic complications [12,13]. Several mecha-
nisms have been proposed to explain the development of diabetic
complications: increased polyol pathway, increased advanced gly-
cation end product (AGE) formation, activation of protein kinase C,
and increased hexoamine pathway ﬂux. All seem to reﬂect a single
hyperglycemia-induced process of oxidative stress [14].
We present evidence that erythrocyte PMRS activity is in-
creased in Rel-T2D (14.76%) and in type 2 diabetic patients
(37.53%) (Fig. 1). The activity of PMRS has been shown to be ele-
vated in erythrocytes from patients with diabetic nephropathy
[15] and in lymphocytes from insulin dependent diabetes mellitus
patients, a disease in which mitochondrial activity is depressed
[16]. A few recent studies have shown that the activity of PMRS
is modulated during aging in animals, providing an efﬁcient addi-
tional cell protection from oxidative stress [5,6,17].Erythrocytes, being the most abundant cells in the blood, have a
crucial role in recycling ASC in blood plasma. Erythrocytes can take
up DHA from the plasma through the GLUT1 glucose transporter.
Inside the cell, DHA can be recycled to ASC via a direct reduction
by glutathione, by glutathione dependent enzymes such as glutare-
doxin and protein-disulﬁde isomerase, and by NADPH-dependent
thioredoxin reductase. Since the rate of release of ASC from eryth-
rocytes to plasma is slow, the role of the recycling of ASC in the
maintenance of plasma ASC levels assumes importance.
Fig. 2 shows an increase in the activity of erythrocyte AFR
reductase in Rel-T2D (23.16%) and T2DM (38.34%). The AFR reduc-
tase driven reduction of extracellular ascorbate free radical has
been shown to be an electrogenic process, indicating that the vec-
torial electron transport is involved in the reduction of extracellu-
lar ascorbate free radical [18]. There is evidence for a decrease in
the free radical scavenging capacity of plasma in diabetics, con-
comitant with a signiﬁcant decrease of plasma vitamin C and an in-
crease of AFR/vitamin C [19]. Our observation of an increase in the
activity of AFR reductase during T2DMmay thus provide increased
recycling of ascorbate between erythrocyte and plasma and thus
help to maintain the antioxidant potential of the plasma during in-
creased oxidative stress which is encountered during diabetes. The
increased activity of erythrocyte AFR reductase in Rel-T2D is an
interesting aspect of the current study, and suggests that an under-
lying oxidative stress condition is present in Rel2D subjects even
before the onset of frank diabetic state.
In conclusion, we present evidence that erythrocyte PMRS and
AFR reductase are elevated in Rel-T2D and T2DM. The increase in
S.I. Rizvi, N. Srivastava / International Journal of Diabetes Mellitus 2 (2010) 119–121 121PMRS and AFR reductase signify compensatory mechanisms to
mitigate increased oxidative stress. These ﬁndings show that an
impaired redox balance may be a cause for disturbance of homeo-
stasis in type 2 diabetic families even before the development of
the disease.Conﬂict of interest
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